Dietary Intervention in Patients with a History of Melanoma
NCT03950635 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 13
Last updated 2024-12-04
Summary
This research trial studies the effects of diet in patients with a history of melanoma. We are studying the impact of 2 different diets; a whole-foods, fiber-rich diet and a ketogenic diet. Participants will be assigned to one of these diets. During this study, participants will be provided all food at no cost for the entire 6-week study. Food can be picked up or shipped to the participant's home. However, participants will need to come into MD Anderson Cancer Center in Houston, TX, for the initial screening visit and for blood tests every 2 weeks during the study.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Dietary Intervention
Consume whole-foods, fiber-rich diet
- DIETARY_SUPPLEMENT
-
Dietary Intervention
Consume high fat, low carbohydrate (ketogenic) diet
- OTHER
-
Questionnaire Administration
Ancillary studies
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Jennifer McQuade · M.D. Anderson Cancer Center
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-04-16
- Primary Completion
- 2024-11-27
- Completion
- 2024-11-27
Countries
- United States
Study Locations
More Related Trials
-
Answering Questions About Vitamin D Supplementation and Sun Exposure in Patients Who Have Undergone Surgery for Stage IB, Stage II, or Stage IIIA Melanoma
NCT00672321 ·Status: UNKNOWN
-
Melanoma Checkpoint and Gut Microbiome Alteration With Microbiome Intervention
NCT03817125 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Impact® as Support to Anti PD1 or Anti PD1 Based Regimen Treatment in Patients With Inoperable Locally Advanced or Metastatic Melanoma
NCT06880198 ·Status: RECRUITING ·Phase: NA
-
A Clinical Study of the Safety and Activity of the Investigational Cell Therapy NEO-PTC-01 in Patients With Advanced Melanoma
NCT04625205 ·Status: TERMINATED ·Phase: PHASE1
-
A Clinical Trial of Adoptive Transfer With Autologous NKT Cells in Metastatic Melanoma Patients
NCT02619058 ·Status: UNKNOWN ·Phase: PHASE1
-
Targeted Intervention for Melanoma Prevention
NCT00394134 ·Status: COMPLETED ·Phase: NA
-
Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma
NCT00003346 ·Status: COMPLETED ·Phase: PHASE2
-
Inhaled Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
NCT00017121 ·Status: COMPLETED ·Phase: PHASE1
-
Intratumoral Injections of LL37 for Melanoma
NCT02225366 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Inducing Systemic Immunity and Regressions in Metastatic Melanoma
NCT02350972 ·Status: COMPLETED ·Phase: PHASE1
-
Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their Families
NCT03677739 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Intratumoral Injection Of Alpha-Gal Glycosphingolipids
NCT00668512 ·Status: COMPLETED ·Phase: PHASE1
-
LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma
NCT06623461 ·Status: RECRUITING ·Phase: PHASE2
-
Duration of Anti-PD-1 Therapy in Metastatic Melanoma
NCT02821013 ·Status: RECRUITING ·Phase: PHASE3
-
Investigating Participation Patterns Among Stage IV Melanoma Patients
NCT06093594 ·Status: NOT_YET_RECRUITING
-
Evaluation of Interferon-Lovastatin Therapy for Malignant Melanoma
NCT00963664 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma
NCT00001296 ·Status: COMPLETED ·Phase: PHASE3
-
Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma
NCT00003747 ·Status: UNKNOWN ·Phase: PHASE1
-
Clinical Trial of Phenformin in Combination With BRAF Inhibitor + MEK Inhibitor for Patients With BRAF-mutated Melanoma
NCT03026517 ·Status: COMPLETED ·Phase: PHASE1
-
3-month Aerobic and Resistance Exercise Intervention for Individuals Diagnosed With Melanoma
NCT03825913 ·Status: TERMINATED ·Phase: NA
-
Phase 1 Study of MPC-6827 and Temozolomide in Metastatic Melanoma
NCT00609011 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
GM-CSF as Adjuvant Therapy of Melanoma
NCT00350597 ·Status: COMPLETED ·Phase: PHASE2
-
Melanoma Metastasized to the Brain and Steroids
NCT03563729 ·Status: RECRUITING ·Phase: PHASE2
-
Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma
NCT00924001 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Effects of Acute and Chronic Exercise on Myeloid-Derived Suppressor Cells in Melanoma Patients
NCT05615883 ·Status: COMPLETED ·Phase: NA